Interpretation of the Meaningfulness of Symptom Reduction with Vibegron in Patients with Overactive Bladder: Analyses from EMPOWUR

INTRODUCTION: Reductions in bothersome symptoms of overactive bladder (OAB) demonstrate improvement in clinical trials, but patient perception of meaningfulness of such improvement is lacking. In the 12-week phase 3 EMPOWUR trial, vibegron significantly reduced average daily number of micturitions,...

Descripción completa

Detalles Bibliográficos
Autores principales: Frankel, Jeffrey, Staskin, David, Varano, Susann, Kennelly, Michael, Newman, Diane K., Rosenberg, Matt T., Jankowich, Rachael A., Shortino, Denise, Mudd, Paul N., Girman, Cynthia J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866263/
https://www.ncbi.nlm.nih.gov/pubmed/34921665
http://dx.doi.org/10.1007/s12325-021-01972-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866263/
https://www.ncbi.nlm.nih.gov/pubmed/34921665
http://dx.doi.org/10.1007/s12325-021-01972-8

Ejemplares similares